Compare Aurora Cannabis Inc (ACB) vs Teradyne, Inc. (TER) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Aurora Cannabis Inc vs Teradyne, Inc. — how do they compare? Aurora Cannabis Inc trades at $2.67 (market cap $165.36M), while Teradyne, Inc. trades at $346.94 (market cap $53.71B). The key difference: Teradyne, Inc. is far larger — about 324.8× Aurora Cannabis Inc's market cap, and Teradyne, Inc. pays a 0.15% dividend while Aurora Cannabis Inc pays none. Which is the better fit depends on your goals.
| ACB | TER | |
|---|---|---|
Market Cap | $165.36M | $53.71B |
Sector | Health | Technology |
52-Week High | $6.23 | $483.84 |
52-Week Low | $2.67 | $90.15 |
Enterprise Value | $99.82M | $53.55B |
Dividend Yield | — | 0.15% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aurora Cannabis (ACB) trades at $2.71, down 4.58% on the day, with a bearish technical outlook. The company reported a net income of $1.59 million in 2025, a significant improvement from a $69 million loss in 2024, though 2026 guidance projects a net loss of $136 million. Revenue grew to $343.29 million in 2025, but faces headwinds from Canadian reimbursement pressures. Analyst consensus is mixed, with 21.43% buy, 57.14% hold, and 21.43% sell ratings.
The stock's low P/B of 0.47 suggests undervaluation, but negative profitability metrics and a projected reset year in 2027 pose risks. Investment appeal hinges on execution in high-margin international medical markets, though volatility and competitive pressures remain key concerns for shareholders.
Teradyne (TER) trades at $343.11, down 7.04% amid a semiconductor sector sell-off, yet maintains strong fundamentals with 22.55% net margins and consistent earnings beats. The stock shows bearish technical signals but benefits from robust AI-driven demand, with 64.5% analyst buy ratings and a $453.60 consensus target suggesting 32% upside. Recent dividend declaration and strong cash flow generation support long-term stability despite near-term volatility.
Outlook remains positive given Teradyne's leadership in semiconductor testing and robotics, with AI infrastructure spending driving growth. Risks include sector cyclicality and premium valuations (P/E 70.4), but earnings momentum and institutional support provide cushion. The stock presents a compelling opportunity for investors seeking AI infrastructure exposure with proven execution capabilities.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Aurora Cannabis Inc
Aurora Cannabis, based in Edmonton, Canada, grows and distributes both medical and recreational cannabis under several brands, including Drift, San Rafael '71, Daily Special, Whistler, Being, and Greybeard. While its main market is Canada, the company has also expanded globally through medical cannabis export agreements.
Read more on ACB →About Teradyne, Inc.
Teradyne provides testing equipment, including automated test equipment for semiconductors, system testing for hard disk drives, circuit boards, and electronics systems and wireless testing for devices. The firm entered the industrial automation market in 2015, into which it sells collaborative and autonomous robots for factory applications. Teradyne serves numerous end markets and geographies directly and indirectly with its products, but its most significant exposure is to semiconductor testing, which made up 71% of 2021 sales. Teradyne serves vertically integrated, fabless, and foundry chipmakers with its equipment.
Read more on TER →
